Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01)
| קרן | National Institute of Allergy and Infectious Diseases/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 28/07/2020 |
| פקולטה | Life Sciences, Medicine |
| תיאור | The purpose of this grant is to invite applications for innovative clinical, and preclinical/translational research to develop therapeutic vaccine strategies to improve treatment outcomes of active tuberculosis (TB) in the presence or absence of HIV co-infection.
Funding: $800,000 per year Duration: 5 years
Research Auhtority due date: 22.6.2 LOI (encouraged) due date: 29.6.20 Full proposal due date: 28.7.20 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 08/03/2020 |
